MedPath

Evaluation of acute normovolemic hemodilution on coagulation during liver surgery.

Phase 1
Conditions
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]
coagulation during liver surgeryAcute normowolemic hemodilution
Registration Number
EUCTR2015-001282-13-BE
Lead Sponsor
Ghent University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

•Adult = 18 years (Female or Male)
•Able to comprehend, sign and date the written informed consent document to participate in the clinical trial.
•Scheduled for liver surgery.

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 50
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 10

Exclusion Criteria

•Active coronary artery disease.
•History of cerebrovascular disease.
•History of congestive heart failure.
•Hemodynamic instable patients.
•Renal dysfunction (creatinine > 2 mg/dL)
•History of coagulopathy.
•Coagulopathy (Platelet count < 100.000 / mm3 or INR > 1,5)
•Anticoagulant therapy.
•Preoperative hemoglobin < 12 g/dL.
•Documented allergy of the IV fluids used in the protocol.
•Morbidly obese patients with BMI > 35.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: To evaluate the effect of acute normovolemic hemodilution with different fluids during liver surgery on coagulation using standard coagulation test, thromboelastography and glasbeat sonoclot.;Secondary Objective: Not applicable;Primary end point(s): coagulopathy during Acute Normowolemic Hemodilution (ANH), defined as a prolongation of the R-value on the tromboelastogram. ;Timepoint(s) of evaluation of this end point: end of ANH
Secondary Outcome Measures
NameTimeMethod
Secondary end point(s): none;Timepoint(s) of evaluation of this end point: not applicable
© Copyright 2025. All Rights Reserved by MedPath